Is Disopyramide Phosphate Capsule, Extended Release in shortage?
Disopyramide Phosphate Capsule, Extended Release is listed by FDA as being discontinued by at least one maker (updated Aug 24, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Norpace CR, Capsule, Extended Release, 100 mg (NDC 0025-2732-31)
Discontinuation of the manufacture of the drug
Maker contact: 800-533-4535
- Norpace CR, Capsule, Extended Release, 150 mg (NDC 0025-2742-31)
Discontinuation of the manufacture of the drug
Maker contact: 800-533-4535
Disopyramide Phosphate Capsule, Extended Release shortage questions
Is Disopyramide Phosphate Capsule, Extended Release in shortage?
Disopyramide Phosphate Capsule, Extended Release is listed by FDA as being discontinued by at least one maker (updated Aug 24, 2026).
What should I do if I can’t get Disopyramide Phosphate Capsule, Extended Release?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.